| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022636 |
| Receipt No. | R000026097 |
| Scientific Title | Clinical trials about the correlation of change and PSA of the MRI (DWI-ADC) after a treatment halfway point and the end of treatment radiotherapy for prostate cancer |
| Date of disclosure of the study information | 2016/06/07 |
| Last modified on | 2019/06/29 (Ver. 5) |
| Basic information | ||
| Public title | Clinical trials about the correlation of change and PSA of the MRI (DWI-ADC) after a treatment halfway point and the end of treatment radiotherapy for prostate cancer | |
| Acronym | Correlation of change and PSA of the MRI after a treatment halfway point and the end of treatment radiotherapy for prostate cancer | |
| Scientific Title | Clinical trials about the correlation of change and PSA of the MRI (DWI-ADC) after a treatment halfway point and the end of treatment radiotherapy for prostate cancer | |
| Scientific Title:Acronym | Correlation of change and PSA of the MRI after a treatment halfway point and the end of treatment radiotherapy for prostate cancer | |
| Region |
|
|
| Condition | |||
| Condition | prostate cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Correlative of examines MRI-ADC and the value with the PSA test in radiotherapy for prostate cancer |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | A correlation is seen in MRI image findings and a value of the blood test PSA |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Performance status is the patient of 0 or 1. The patients that a written consent was obtained. | |||
| Key exclusion criteria | Patient with no informed consent. | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gifu Municipal Hospital | ||||||
| Division name | Department of Radiation Oncology | ||||||
| Zip code | 5008523 | ||||||
| Address | 7-1 kashima-cho Gifu Japan | ||||||
| TEL | 058-251-1101 | ||||||
| c.bluered@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gifu Municipal Hospital | ||||||
| Division name | Department of Radiation Oncology | ||||||
| Zip code | 5008523 | ||||||
| Address | Gifu | ||||||
| TEL | +819076730893 | ||||||
| Homepage URL | |||||||
| c.bluered@gmail.com | |||||||
| Sponsor | |
| Institute | Gifu Municipal Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Asahi University |
| Address | 3-23 Hashimoto-cho |
| Tel | +819076730893 |
| c.bluered@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We observe a state of prostate cancer of the patients and a correlation with the blood test PSA using noninvasive MR imaging |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026097 |